Skip to main content

Genetisch bedingte Stoffwechselerkrankungen des Gastrointestinaltrakts

  • Chapter
  • First Online:
Viszeralmedizin

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Subscribe and save

Springer+ Basic
$34.99 /Month
  • Get 10 units per month
  • Download Article/Chapter or eBook
  • 1 Unit = 1 Article or 1 Chapter
  • Cancel anytime
Subscribe now

Buy Now

Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 129.00
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Hardcover Book
USD 149.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Similar content being viewed by others

Literatur

Literatur zu Abschnitt 41.1 und 41.2

Literatur zu Abschnitt 41.3

  • Anderson KE, Bloomer JR, Bonkovsky HL et al (2005) Recommendations for the diagnosis and treatment of the acute porphyrias. Ann Intern Med 142:439–450

    Article  PubMed  Google Scholar 

  • Bonkovsky HL (1993) Advances in understanding and treating ‚the little imitator’, acute porphyria. Gastroenterology 105:590–594

    CAS  PubMed  Google Scholar 

  • Bonkowsky HL, Tschudy DP, Collins A et al (1971) Repression of the overproduction of porphyrin precursors in acute intermittent porphyria by intravenous infusions of hematin. Proc Natl Acad Sci U S A 68:2725–2729

    Article  PubMed Central  CAS  PubMed  Google Scholar 

  • Doss M, Verspohl F (1981) The „glucose effect“ in acute hepatic porphyrias and in experimental porphyria. Klin Wochenschr 59:727–735

    Article  CAS  PubMed  Google Scholar 

  • Doss M, von Tiepermann R, Schneider J, Schmid H (1979) New type of hepatic porphyria with porphobilinogen synthase defect and intermittent acute clinical manifestation. Klin Wochenschr 57:1123–1127

    Article  CAS  PubMed  Google Scholar 

  • Doss MO (1982) Hepatic porphyrias: pathobiochemical, diagnostic and therapeutic implications. Prog Liver Dis 7:573–597

    CAS  PubMed  Google Scholar 

  • Fargion S, Piperno A, Cappellini MD et al (1992) Hepatitis C virus and porphyria cutanea tarda: evidence of a strong association. Hepatology 16:1322–1326

    Article  CAS  PubMed  Google Scholar 

  • Handschin C, Lin J, Rhee J et al (2005) Nutritional regulation of hepatic heme biosynthesis and porphyria through PGC-1alpha. Cell 122:505–515

    Article  CAS  PubMed  Google Scholar 

  • Ippen H (1977) Treatment of porphyria cutanea tarda by phlebotomy. Semin Hematol 14:253–259

    CAS  PubMed  Google Scholar 

  • Kordac V, Semradova M (1974) Treatment of porphyria cutanea tarda with chloroquine. Br J Dermatol 90:95–100

    Article  CAS  PubMed  Google Scholar 

  • Köstler E, Wollina U (2005) Therapy of porphyria cutanea tarda. Expert Opin Pharmacother 6:377–383

    Article  PubMed  Google Scholar 

  • Puy H, Gouya L (2010) Porphyrias. Lancet 375:924–937

    Article  CAS  PubMed  Google Scholar 

  • Seth AK, Badminton MN et al (2007) Liver transplantation for porphyria: who, when and how? Liver Transpl 13:1219–1227

    Article  PubMed  Google Scholar 

  • Stölzel U, Doss MO, Mirza D et al (1987) Gastroenterologic and neurologic manifestations in acute intermittent porphyria. Med Klin (Munich) 82:520–525

    Google Scholar 

  • Stölzel U, Köstler E, Koszka C et al (1995) Low prevalence of hepatitis C virus infection in porphyria cutanea tarda in Germany. Hepatology 21:1500–1503

    Article  PubMed  Google Scholar 

  • Stölzel U, Brosche C, Koszka C et al (2009) Safe and probably safe drugs in acute porphyria. Cell Mol Biol 55:147–151

    PubMed  Google Scholar 

  • Stölzel U, Köstler E, Schuppan D et al (2003) Hemochromatosis (HFE) gene mutations and response to chloroquine in porphyria cutanea tarda. Arch Dermatol 139:309–313

    Article  PubMed  Google Scholar 

  • Stölzel U, Stauch T, Doss MO et al (2014) Heme synthesis defects and porphyrias. In: Blau N (Hrsg) Physician‘s guide to the diagnosis, treatment, and follow‐up of inherited metabolic diseases. Springer, Berlin, S 541–554

    Chapter  Google Scholar 

  • Wahlin S, Aschan J, Björnstedt M et al (2007) Curative bone marrow transplantation in erythropoietic protoporphyria after reversal of severe cholestasis. J Hepatol 46:174–179

    Article  PubMed  Google Scholar 

  • Whatley S, Ducamp S (2008) C-Terminal Deletions in the ALAS2 gene lead to gain of function and cause X-linked dominant protoporphyria without anemia or iron overload. Am J Hum Genet 83:408–414

    Article  PubMed Central  CAS  PubMed  Google Scholar 

  • Wollina U, Köstler E, Koch A et al (2009) Does chloroquine therapy of porphyria cutanea tarda influence liver pathology? Int J Dermatol 48:1250–1253

    Article  CAS  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Editor information

Editors and Affiliations

Rights and permissions

Reprints and permissions

Copyright information

© 2015 Springer-Verlag Berlin Heidelberg

About this chapter

Cite this chapter

Stremmel, W., Merle, U., Stölzel, U., Doss, M.O. (2015). Genetisch bedingte Stoffwechselerkrankungen des Gastrointestinaltrakts. In: Erckenbrecht, J., Jonas, S. (eds) Viszeralmedizin. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-642-14301-4_41

Download citation

  • DOI: https://doi.org/10.1007/978-3-642-14301-4_41

  • Published:

  • Publisher Name: Springer, Berlin, Heidelberg

  • Print ISBN: 978-3-642-14300-7

  • Online ISBN: 978-3-642-14301-4

  • eBook Packages: Medicine (German Language)

Publish with us

Policies and ethics